A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants
Clinical trial NCT06627088 · COMPLETED
Trial details
- NCT number
- NCT06627088
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2024-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.